Evidence map›Paper›PMID 42280238›Full record

ArticleMolecules (Basel, Switzerland)2026

Development and Characterization of Intravenous Nanoemulsions Loaded with

Katarzyna Dominiak, Aleksandra Gostyńska-Stawna, Karina Sommerfeld-Klatta, Magdalena Ratajczak, Violetta Krajka-Kuźniak, Maciej Stawny

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katarzyna DominiakDepartment of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 3 Rokietnicka, 60-802 Poznan, Poland.
Aleksandra Gostyńska-StawnaDepartment of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 3 Rokietnicka, 60-802 Poznan, Poland.ORCID 0000-0003-3401-9503
Karina Sommerfeld-KlattaDepartment of Toxicology, Poznan University of Medical Sciences, 3 Rokietnicka, 60-806 Poznan, Poland.
Magdalena RatajczakDepartment of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, 3 Rokietnicka, 60-806 Poznan, Poland.ORCID 0000-0002-1553-5564
Violetta Krajka-KuźniakDepartment of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 3 Rokietnicka, 60-806 Poznan, Poland.ORCID 0000-0001-7275-0298
Maciej StawnyDepartment of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 3 Rokietnicka, 60-802 Poznan, Poland.ORCID 0000-0001-5106-5937

Funding

National Science Centre OPUS no. 2022/45/B/NZ7/01056
6 · The paper itself

Abstract

Honokiol (HON) and magnolol (MAG), hepatoprotective neolignans from

Indexed as

Biphenyl CompoundsLignansMagnoliaNanoparticlesAllyl CompoundsAnimalsCell LineEmulsionsHumansParticle SizePhenolsAllyl CompoundsBiphenyl CompoundsEmulsionshonokiolLignansmagnololPhenolshigh-pressure homogenizationnanoemulsionneolignansparenteral nutritionPFAT5THLE-2 cells

Identifiers

PMID42280238
PMCPMC13257743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.